Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 1,380,000 shares, a drop of 9.2% from the April 30th total of 1,520,000 shares. Approximately 5.9% of the company’s stock are sold short. Based on an […]

Related Keywords

United States , , York Mellon Corp , Barclays Plc , Sg Americas Securities , Nasdaq , Ikena Oncology Inc , Ikena Oncology , Get Free Report , New York Mellon Corp , Capital Management , Adage Capital Partners , Capital Partners , Ikena Oncology Daily ,